Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses ———— — Research & development ———— — Operating income -26.36 M40.06 M4.99 M7.23 M 25.91 M Non-Operating Income, Total 9.77 M5.46 M-6.2 M6.04 M 15.07 M Interest expense, net of interest capitalized 2.83 M2.97 M3.97 M2.44 M 12.2 M Non-Operating Income, excl. Interest Expenses 6.94 M2.49 M-10.17 M3.61 M 2.87 M Unusual income/expense ———— — Pretax income -21.44 M41.63 M-3.42 M9.26 M 26.03 M Equity in earnings ———— — Taxes -7.73 M14.75 M6.71 M3.08 M 16.82 M Non-controlling/minority interest -12.79 M14.89 M133 K2.45 M 4.69 M After tax other income/expense 38 K-56 K-32 K-1 000 -51 K Net income before discontinued operations -930 K11.99 M-10.27 M3.73 M 4.52 M Discontinued operations ———— — Net income -930 K11.99 M-10.27 M3.73 M 4.52 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders -930 K11.99 M-10.27 M3.7 M 4.5 M Basic earnings per share (Basic EPS) -0.030.37-0.310.11 0.14 Diluted earnings per share (Diluted EPS) -0.030.36-0.310.12 0.14 Average basic shares outstanding 32.62 M32.84 M32.94 M32.86 M — Diluted shares outstanding 32.62 M33.24 M32.94 M33.13 M — EBITDA 225.4 M570.22 M436.83 M207.79 M 1.44 B EBIT 214.98 M559.7 M426.13 M196.83 M 1.4 B Cost of revenue ———— — Other cost of goods sold ———— — Depreciation & amortization (cash flow) 10.42 M10.51 M10.7 M10.96 M 42.6 M